HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

COVID-19 Mathematical Model Reveals Innate Immunity Plays Larger Role in Controlling SARS-CoV-2 Viral Load than Adaptive Immunity

By HospiMedica International staff writers
Posted on 25 Jan 2021
Image: COVID-19 Mathematical Model Reveals Innate Immunity Plays Larger Role in Controlling SARS-CoV-2 Viral Load than Adaptive Immunity (Photo courtesy of vladdon/Shutterstock.com)
Image: COVID-19 Mathematical Model Reveals Innate Immunity Plays Larger Role in Controlling SARS-CoV-2 Viral Load than Adaptive Immunity (Photo courtesy of vladdon/Shutterstock.com)
Researchers have developed a mathematical model of SARS-CoV-2 infection that reveals a key role for the innate immune system in controlling viral load.

The mathematical model was developed by researchers at Houston Methodist (Houston, TX, USA) and predicts the viral load over time in organs that express the ACE-2 receptor, which is necessary for SARS-CoV-2’s entry into cells. The researchers aimed to improve upon the existing models for investigating virus-host interactions to simulate the whole-body dynamics of SARS-CoV-2 infection. Some of the parameters used in the model, such as the levels of various immune cells in the human body, were already known, whereas others, such as the infection rate of target cells, were estimated from published experimental data from COVID-19-infected hamsters.

Once the team had developed a simplified model, they used human data to make a more complete one that also included adaptive immunity. When the researchers used the model to simulate different conditions, they found that innate immunity played a larger role in controlling viral load than adaptive immunity, and that it was important to begin antiviral or interferon therapy as soon as possible after the onset of symptoms.

Related Links:
Houston Methodist

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Endoscopy Display
E190

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more